These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1868326)

  • 1. Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons.
    Kalia M
    Brain Res; 1991 May; 548(1-2):111-25. PubMed ID: 1868326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies.
    Appel NM; Contrera JF; De Souza EB
    J Pharmacol Exp Ther; 1989 Jun; 249(3):928-43. PubMed ID: 2732954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of short- and long-term effects of DL-fenfluramine on the serotonergic innervation of the rat hippocampal formation.
    Sotelo C
    Brain Res; 1991 Feb; 541(2):309-26. PubMed ID: 2054644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography.
    Appel NM; Mitchell WM; Contrera JF; De Souza EB
    Synapse; 1990; 6(1):33-44. PubMed ID: 2144664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New evidence for a loss of serotonergic nerve terminals in rats treated with d,l-fenfluramine.
    Westphalen RI; Dodd PR
    Pharmacol Toxicol; 1993; 72(4-5):249-55. PubMed ID: 8372042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism.
    Bonanno G; Fassio A; Severi P; Ruelle A; Raiteri M
    J Neurochem; 1994 Sep; 63(3):1163-6. PubMed ID: 8051559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data.
    Zaczek R; Battaglia G; Culp S; Appel NM; Contrera JF; De Souza EB
    J Pharmacol Exp Ther; 1990 Apr; 253(1):104-12. PubMed ID: 2329498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.
    Kleven MS; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1988 Sep; 246(3):822-8. PubMed ID: 2458447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-, L- and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain.
    Kleven MS; Seiden LS
    Brain Res; 1989 Dec; 505(2):351-3. PubMed ID: 2598057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives.
    Mamounas LA; Mullen CA; O'Hearn E; Molliver ME
    J Comp Neurol; 1991 Dec; 314(3):558-86. PubMed ID: 1814975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats.
    Laferrere B; Wurtman RJ
    Brain Res; 1989 Dec; 504(2):258-63. PubMed ID: 2480833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic D-fenfluramine administration on rat hypothalamic serotonin levels and release.
    Schaechter JD; Wurtman RJ
    Life Sci; 1989; 44(4):265-71. PubMed ID: 2464733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DL-fenfluramine increases the 5-HT synthesis rate in the terminals while decreasing it in the cell bodies of the rat brain.
    Mück-Seler D; Diksic M
    Brain Res; 1996 Oct; 737(1-2):45-50. PubMed ID: 8930348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenfluramine depletes serotonin from the developing cortex and alters thalamocortical organization.
    Bennett-Clarke CA; Lane RD; Rhoades RW
    Brain Res; 1995 Dec; 702(1-2):255-60. PubMed ID: 8846085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release.
    Fuller RW; Snoddy HD; Robertson DW
    Pharmacol Biochem Behav; 1988 Jul; 30(3):715-21. PubMed ID: 2463643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent blockade of potassium-evoked serotonin release from rat frontocortical terminals after fluoxetine administration.
    Gardier AM; Wurtman RJ
    Brain Res; 1991 Feb; 540(1-2):325-30. PubMed ID: 1711396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anorectic effect and brain concentrations of D-fenfluramine in the marmoset: relationship to the in vivo and in vitro effects on serotonergic mechanisms.
    Caccia S; Anelli M; Fracasso C; Frittoli E; Giorcelli P; Gobbi M; Taddei C; Garattini S; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):306-12. PubMed ID: 8479546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats.
    Kehne JH; Padich RA; McCloskey TC; Taylor VL; Schmidt CJ
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):95-106. PubMed ID: 8935804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity.
    Baumann MH; Ayestas MA; Dersch CM; Partilla JS; Rothman RB
    Ann N Y Acad Sci; 2000 Sep; 914():172-86. PubMed ID: 11085319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.